Skip to main content
. 2018 Apr 30;2(9):969–978. doi: 10.1182/bloodadvances.2017013979

Table 2.

Treatment comparisons for pulmonary function and hand-grip strength

Variables Vitamin D3 100 000 IU/mo Vitamin D3 12 000 IU/mo P for interaction between treatment group and time
Pulmonary function tests
 FVC, % predicted n = 28 n = 30 0.52
  Baseline 85.5 ± 2.8 90.2 ± 2.3
  Treatment year 1 85.2 ± 2.7 92.4 ± 2.3
  Treatment year 2 85.0 ± 2.5 92.1 ± 2.5
 FEV1, % predicted n = 28 n = 30 0.81
  Baseline 80.4 ± 2.4 84.9 ± 2.3
  Treatment year 1 79.1 ± 2.7 85.3 ± 2.1
  Treatment year 2 78.9 ± 2.8 84.5 ± 2.0
 FEV1/FVC ratio, % n = 28 n = 30 0.95
  Baseline 84.0 ± 1.5 83.3 ± 1.5
  Treatment year 1 82.6 ± 1.0 81.7 ± 1.3
  Treatment year 2 82.2 ± 1.5 81.6 ± 1.2
 FEF25-75, % predicted n = 28 n = 30 0.87
  Baseline 69.8 ± 5.2 68.8 ± 4.9
  Treatment year 1 62.9 ± 4.4 64.8 ± 4.3
  Treatment year 2 62.8 ± 4.4 65.6 ± 4.3
 RV/TLC ratio, % n = 23 n = 20 0.96
  Baseline 26.9 ± 1.3 25.1 ± 1.6
  Treatment year 1 25.4 ± 1.8 22.6 ± 1.9
  Treatment year 2 22.8 ± 1.6 21.8 ± 1.9
 DLCO, % predicted n = 20 n = 19 0.69
  Baseline 68.0 ± 3.2 72.3 ± 3.9
  Treatment year 1 62.9 ± 3.2 67.8 ± 2.4
  Treatment year 2 68.1 ± 3.8 72.9 ± 2.9
 FENO, ppb n = 28 n = 30 0.54
  Baseline 19.3 ± 2.7 16.9 ± 2.1
  Treatment year 1 20.5 ± 3.5 16.1 ± 2.1
  Treatment year 2 18.1 ± 2.7 16.4 ± 2.4
 MIP, cm H2O n = 23 n = 19 1.00
  Baseline 69.1 ± 5.6 59.9 ± 5.3
  Treatment year 1 78.7 ± 6.1 80.4 ± 6.3
  Treatment year 2 77.4 ± 5.0 74.6 ± 4.7
 MEP, cm H2O n = 23 n = 19 0.70
  Baseline 66.3 ± 3.9 66.3 ± 5.4
  Treatment year 1 60.4 ± 3.3 57.3 ± 3.1
  Treatment year 2 58.7 ± 3.4 56.2 ± 4.0
Hand-grip strength
 Right hand, pounds force n = 25 n = 27 0.81
  Baseline 21.2 ± 3.2 16.9 ± 2.2
  Treatment year 1 20.6 ± 3.0 16.6 ± 2.4
  Treatment year 2 23.8 ± 4.1 17.4 ± 2.9
 Left hand, pounds force n = 25 n = 27 0.97
  Baseline 19.9 ± 3.4 16.0 ± 2.1
  Treatment year 1 19.0 ± 3.4 13.6 ± 2.4
  Treatment year 2 19.6 ± 3.6 15.8 ± 2.8
 Dominant hand, pounds force n = 25 n = 27 0.24
  Baseline 21.2 ± 3.2 17.1 ± 2.2
  Treatment year 1 20.8 ± 3.0 17.3 ± 2.4
  Treatment year 2 23.8 ± 4.1 18.1 ± 3.1

All data are mean ± SEM.